- Home
- RANI vs TENX Comparison
RANI vs TENX Comparison
Compare RANI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- TENX
- Stock Information
- Founded
- RANI 2012
- TENX 1967
- Country
- RANI United States
- TENX United States
- Employees
- RANI N/A
- TENX N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- RANI Health Care
- TENX Health Care
- Exchange
- RANI Nasdaq
- TENX Nasdaq
- Market Cap
- RANI 23.2M
- TENX 25.8M
- IPO Year
- RANI 2021
- TENX N/A
- Fundamental
- Price
- RANI $0.55
- TENX $5.97
- Analyst Decision
- RANI Strong Buy
- TENX Strong Buy
- Analyst Count
- RANI 4
- TENX 3
- Target Price
- RANI $7.75
- TENX $15.00
- AVG Volume (30 Days)
- RANI 1.1M
- TENX 25.8K
- Earning Date
- RANI 08-07-2025
- TENX 08-13-2025
- Dividend Yield
- RANI N/A
- TENX N/A
- EPS Growth
- RANI N/A
- TENX N/A
- EPS
- RANI N/A
- TENX N/A
- Revenue
- RANI $1,200,000.00
- TENX N/A
- Revenue This Year
- RANI N/A
- TENX N/A
- Revenue Next Year
- RANI N/A
- TENX N/A
- P/E Ratio
- RANI N/A
- TENX N/A
- Revenue Growth
- RANI N/A
- TENX N/A
- 52 Week Low
- RANI $0.39
- TENX $3.25
- 52 Week High
- RANI $3.75
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- RANI 53.01
- TENX 48.76
- Support Level
- RANI $0.50
- TENX $5.82
- Resistance Level
- RANI $0.59
- TENX $5.95
- Average True Range (ATR)
- RANI 0.04
- TENX 0.21
- MACD
- RANI 0.00
- TENX -0.03
- Stochastic Oscillator
- RANI 63.16
- TENX 37.62
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.